Ruth E. Thom
Impact in
- Infectious Diseases top 5%
- Viral Infections and Outbreaks Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
Papers in
-
- Viral Infections and Outbreaks Research 6
- Tuberculosis Research and Epidemiology 2
- SARS-CoV-2 detection and testing 1
-
- Sepsis Diagnosis and Treatment 1
- Burkholderia infections and melioidosis 1
- Virology and Viral Diseases 1
- Co-authors
- Riccardo V. D’Elia (2 shared papers)Ann Williams (2 shared papers)Julia A. Tree (2 shared papers)Michael J. Elmore (2 shared papers)Philip David Marsh (2 shared papers)Francis A. Drobniewski (1 shared paper)Simon Colin Andrews (1 shared paper)Lyn M. O’Brien (2 shared papers)
- Journals
- Vaccine (2 papers)Emerging Microbes & Infections (1 paper)Frontiers in Immunology (1 paper)Microbiology Spectrum (1 paper)PLoS Medicine (1 paper)
- Partner nations
- United KingdomGermanyBelgium
In The Last Decade
Ruth E. Thom
12 papers receiving 787 citations
Ruth E. Thom's Hit Papers
Peers
Comparison fields: 5 of 79
- Infectious Diseases 575
- Chemical Health and Safety 2
- Public Health, Environmental and Occupational Health 74
- Epidemiology 62
- Virology 8
Countries citing papers authored by Ruth E. Thom
This map shows the geographic impact of Ruth E. Thom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth E. Thom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth E. Thom more than expected).
Fields of papers citing papers by Ruth E. Thom
This network shows the impact of papers produced by Ruth E. Thom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth E. Thom. The network helps show where Ruth E. Thom may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth E. Thom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea Hit paper breakdown → | 2016 | 409 |
| 2 | 2015 | 241 | |
| 3 | 2016 | 39 | |
| 4 | 2020 | 36 | |
| 5 | 2012 | 20 | |
| 6 | 2024 | 17 | |
| 7 | 2016 | 11 | |
| 8 | 2019 | 11 | |
| 9 | 2020 | 10 | |
| 10 | 2010 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2023 | 2 |
About Ruth E. Thom
Ruth E. Thom is a scholar working on Infectious Diseases, Epidemiology, Immunology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 12 papers that have together received 809 indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (6 papers), Tuberculosis Research and Epidemiology (2 papers), SARS-CoV-2 detection and testing (1 paper), Sepsis Diagnosis and Treatment (1 paper), Burkholderia infections and melioidosis (1 paper), Virology and Viral Diseases (1 paper), Immune Response and Inflammation (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Infectious Diseases (575 citations), Chemical Health and Safety (2 citations), Public Health, Environmental and Occupational Health (74 citations), Epidemiology (62 citations) and Virology (8 citations). Ruth E. Thom has collaborated with scholars based in United Kingdom, Germany and Belgium. Frequent co-authors include Riccardo V. D’Elia, Ann Williams, Julia A. Tree, Michael J. Elmore, Philip David Marsh, Francis A. Drobniewski, Simon Colin Andrews, Lyn M. O’Brien, Lin S. Eastaugh and Sophie J. Smither. Their work appears in journals such as Vaccine, Emerging Microbes & Infections, Frontiers in Immunology, Microbiology Spectrum and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.